Skip to content
Dendreon
  • News
  • Contact Us
  • About
  • Science and Services
    • Cellular Therapy Manufacturing
    • Provenge Immunotherapy
  • Publications
  • Careers
Survival Outcomes with PROVENGE in a Placebo-controlled, Randomized Phase 3 study
July 29, 2010

Survival Outcomes with PROVENGE in a Placebo-controlled, Randomized Phase 3 study

  • Topics: Clinical Outcomes, Clinical Study, IMPACT Phase 3
  • Published In: New England Journal of Medicine
Read the full article
LinkedInShareTweet
Dendreon
© Dendreon Pharmaceuticals LLC. All Rights Reserved. 2023.
  • Privacy Policy
  • Legal Notice
  • Site Map
  • Linkedin
  • Facebook
  • Twitter